Dr. Kyle Cheng, MD

Dr. Cheng practices at Santa Monica Surgicenter in Santa Monica, California.

Dr. Cheng's NPI, 1306103064, was assigned on April 19, 2012. Dr. Cheng graduated from Drexel University College Of Medicine in 2012. Dr. Cheng holds California license 149110.

Dr. Cheng's primary practice is Santa Monica Surgicenter, at 2001 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5550.

Dr. Cheng's primary practice is Santa Monica Surgicenter in Santa Monica, California. Dr. Cheng is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is UCLA Medical Group. Dmand AI also links Dr. Cheng to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cheng practices, 4 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Cheng's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Cheng is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Cheng's licenses on file in 3 states: California, Virginia and District of Columbia.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, corns and calluses, itchy rashes, psoriasis and rash among the conditions Dr. Cheng treats.

CMS data shows 1,479 Medicare services from Dr. Cheng across 16 procedure codes in 2024, for 535 Medicare patients. Medicare paid $103,870 for them.

CMS counts 535 Medicare patients who saw Dr. Cheng in 2024. The largest group is 65 to 74, with 238 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 31% are also on Medicaid. Their average risk score is 2.11, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cheng's median patient age at 57, with 52% women.

In 2024, Dr. Cheng wrote 1,279 Medicare Part D claims for 347 patients. 72% of them were for generic drugs. CMS names the drug for 1,069 of them, across 31 drugs with 11 or more claims each, at $2,375,862 in total drug cost. In 2023, CMS named 882 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Cheng for performance year 2024, reported as part of a group. Dr. Cheng accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Cheng as offering telehealth. CMS counts 381 procedures of removal of skin lesions by Dr. Cheng, more than 84% of the clinicians it reports for that procedure.

Dmand AI links 12 papers to Dr. Cheng, published from 2011 to 2024. 2019 was the busiest year, with 3. The most frequent topics are Skin, Dermatologic Agents and Dermatology. Dr. Cheng has published most often in J Am Acad Dermatol. Dr. Cheng's most frequent co-authors are Daniel Q. Bach, MD, Nolan Maloney, MD and Jason Jinseok Yang, MD.

CMS Open Payments shows 208 general payments to Dr. Cheng from 21 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 63% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $5,229.

Dr. Cheng graduated from Drexel University College Of Medicine in 2012.

Dr. Cheng is in network with 15 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.